CAS NO: | 60-82-2 |
生物活性 | Phloretin (NSC 407292; RJC 02792) is a flavonoid extracted fromMalus pumilaMill., has anti-inflammatory activities. Phloridzin is a specific, competitive and orally active inhibitor ofsodium/glucose cotransportersin the intestine (SGLT1) and kidney (SGLT2). Phloretin inhibits Yeast-madeGLUT1as well as Human erythrocyteGLUT1withIC50values of 49 μM and 61 μM, respectively[1].Phloretin has the potential for the treatment of rheumatoid arthritis (RA) and allergic airway inflammation[4]. | ||||||||||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||||||||||
体外研究 (In Vitro) | Phloretin induced obvious cytotoxicity against BEL-7402 cells with IC50of 89.23 μM[2].Phloretin (40-160 μM; 24 hours) induces BEL-7402 cell apoptosis though the mitochondrial pathway, the cells exposed to phloretin exhibits nuclear chromatin condensation and increased fluorescence intensity. The caspase-9 reaches the peak level at 12 h, and leak levels of caspase-6 and caspase-3 activities occurrs 18 and 24 h after the exposure, respectively[2].Phloretin (0-100 μM; 24 hours) has effects on transcription factors of adipogenesis in differentiated 3T3-L1 adipocytes, decreases PPAR-γ, C/EBPα and C/EBPβ as a dose-dependent manner[3].Phloretin (0-100 μM; 24 hours) has effects on the AMPK pathway in differentiated 3T3-L1 adipocytes, increases the phosphorylation of substrate ACC-1, AMPK in PT-treated cells[3]. Apoptosis Analysis[2]
Western Blot Analysis[3]
Western Blot Analysis[3]
| ||||||||||||||||||||||||
体内研究 (In Vivo) | Phloretin (oral administration; 50 or 100 mg/kg; once daily) decreases oxidative stress and diminished levels of malondialdehyde (MDA) and hydrogen peroxide (H2O2) in paw tissue, reduces productivity of anti-collagen antibodies in serum[3].
| ||||||||||||||||||||||||
分子量 | 274.27 | ||||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||||
Formula | C15H14O5 | ||||||||||||||||||||||||
CAS 号 | 60-82-2 | ||||||||||||||||||||||||
中文名称 | 根皮素 | ||||||||||||||||||||||||
结构分类 |
| ||||||||||||||||||||||||
来源 |
| ||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
储存方式 |
| ||||||||||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(182.30 mM;Need ultrasonic) H2O : 0.1 mg/mL(0.36 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |